Dr. Mark McClellan joined Johnson & Johnson’s board of directors after leaving the FDA, but the connection often isn’t mentioned in research papers or public events.
A father and son suffered serious hand injuries nine days apart. They both needed surgery and lots of follow-up occupational therapy to rehab their hands. But insurance paid for just a fraction of those OT bills, and the family owed more than $8,500.
The surgeon and writer has been named to head a project by Amazon, Bershire-Hathway and JP Morgan to reduce health costs. He said he wants to help doctors “do the right thing” in delivering care.
As the opioid epidemic rages, a Johns Hopkins surgeon and researcher is leading an effort to curb overprescribing by offering procedure-specific guidelines to ensure that post-surgical patients leave the hospital with enough, but not too much, pain medication.